Qube Research & Technologies LTD Biomarin Pharmaceutical Inc Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $1.1 Million - $1.37 Million	-14,835 Reduced 99.91%	14 $1,000
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $361,975 - $427,581	4,319 Added 41.02%	14,849 $1.3 Million
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $5.42 Million - $7.01 Million	-71,145 Reduced 87.11%	10,530 $1.02 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $34.7 Million - $38.5 Million	-407,530 Reduced 83.3%	81,675 $7.23 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.08 Million - $1.25 Million	12,454 Added 2.61%	489,205 $42.4 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $18.6 Million - $24.8 Million	211,481 Added 79.72%	476,751 $46.4 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $13.8 Million - $18.5 Million	169,933 Added 178.24%	265,270 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7.83 Million - $9.24 Million	95,337 New	95,337 $8.08 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $19.2 Million - $23.3 Million	-268,780 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $20 Million - $24.9 Million	268,780 New	268,780 $20.7 Million
Q4 2021 Feb 01, 2022	SELL	$71.72 - $91.47 $1.74 Million - $2.21 Million	-24,205 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $766,542 - $876,238	10,252 Added 73.48%	24,205 $1.87 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $241,405 - $271,073	3,197 Added 29.72%	13,953 $1.16 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $803,795 - $975,461	10,756 New	10,756 $812,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $3.78 Million - $4.7 Million	-52,118 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $3.3 Million - $6.02 Million	45,906 Added 738.99%	52,118 $3.97 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $494,164 - $771,654	6,212 New	6,212 $766,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $430,483 - $543,597	-6,387 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$80.35 - $93.9 $187,536 - $219,162	2,334 Added 57.59%	6,387 $547,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $341,262 - $399,706	4,053 New	4,053 $360,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $216,698 - $286,813	-2,704 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $253,959 - $285,866	2,704 New	2,704 $262,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account